stars 1 stars 2 stars 3

Genomill is unlocking the true potential of NGS for everyday healthcare with Geno1®, a radically rethought sequencing library preparation based on circular DNA and PCR-free workflows. It combines hybrid-capture–like performance with amplicon-level simplicity: targeted sequencing with minimal steps and the fastest turn-around time compared to other commercial tests. This simplicity makes sequencing faster to run, easier to automate, and practical even in low-infrastructure environments. By enabling decentralized sequencing without compromising sensitivity or scalability, Geno1® changes how next-generation sequencing can be applied in real-world healthcare. Find out more at www.genomill.com

Genomill Questions

The Genomill annual revenue was $5 million in 2026.

Manu Tamminen is the CEO, Co-founder of Genomill.

8 people are employed at Genomill.

The NAICS codes for Genomill are [54, 5417, 541713, 54171, 541].

The SIC codes for Genomill are [87, 873].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users